| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | Chief Discovery Officer | Common Stock | 298,541 | $1,806,173 | $6.05 | 14 Nov 2022 | Direct |
| BIOCRYST PHARMACEUTICALS INC | Chief Discovery Officer | Emp. Stock Option (Right to Buy) | 0 | 14 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 Nov 2022 | 5 | -$295,428 | 4 | Chief Discovery Officer | 16 Nov 2022, 15:19 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 07 Mar 2022 | 1 | -$343,200 | 4 | Chief Discovery Officer | 09 Mar 2022, 15:24 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 14 Dec 2021 | 2 | $0 | 4 | Chief Discovery Officer | 16 Dec 2021, 16:09 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 07 Dec 2021 | 3 | -$73,960 | 4 | Chief Discovery Officer | 09 Dec 2021, 15:38 |